Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Intravenous (IV) Therapy and Vein Access Market, by End User
1.4.2 North America Intravenous (IV) Therapy and Vein Access Market, by Application
1.4.3 North America Intravenous (IV) Therapy and Vein Access Market, by Type
1.4.4 North America Intravenous (IV) Therapy and Vein Access Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Intravenous (IV) Therapy and Vein Access Market
Chapter 4. North America Intravenous (IV) Therapy and Vein Access Market by End User
4.1 North America Hospitals Market by Country
4.2 North America Ambulatory Surgical Center Market by Country
4.3 North America Clinics Market by Country
Chapter 5. North America Intravenous (IV) Therapy and Vein Access Market by Application
5.1 North America Medication Administration Market by Country
5.2 North America Blood Based Products Market by Country
5.3 North America Nutrition & Buffer Solution Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Intravenous (IV) Therapy and Vein Access Market by Type
6.1 North America Intravenous Catheters Market by Country
6.2 North America Infusion Pumps Market by Country
6.3 North America Hypodermic Needles Market by Country
6.4 North America Implantable Ports Market by Country
6.5 North America Others Market by Country
Chapter 7. North America Intravenous (IV) Therapy and Vein Access Market by Country
7.1 US Intravenous (IV) Therapy and Vein Access Market
7.1.1 US Intravenous (IV) Therapy and Vein Access Market by End User
7.1.2 US Intravenous (IV) Therapy and Vein Access Market by Application
7.1.3 US Intravenous (IV) Therapy and Vein Access Market by Type
7.2 Canada Intravenous (IV) Therapy and Vein Access Market
7.2.1 Canada Intravenous (IV) Therapy and Vein Access Market by End User
7.2.2 Canada Intravenous (IV) Therapy and Vein Access Market by Application
7.2.3 Canada Intravenous (IV) Therapy and Vein Access Market by Type
7.3 Mexico Intravenous (IV) Therapy and Vein Access Market
7.3.1 Mexico Intravenous (IV) Therapy and Vein Access Market by End User
7.3.2 Mexico Intravenous (IV) Therapy and Vein Access Market by Application
7.3.3 Mexico Intravenous (IV) Therapy and Vein Access Market by Type
7.4 Rest of North America Intravenous (IV) Therapy and Vein Access Market
7.4.1 Rest of North America Intravenous (IV) Therapy and Vein Access Market by End User
7.4.2 Rest of North America Intravenous (IV) Therapy and Vein Access Market by Application
7.4.3 Rest of North America Intravenous (IV) Therapy and Vein Access Market by Type
Chapter 8. Company Profiles
8.1 B. Braun Melsungen AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent Strategies and Developments
8.1.5.1 Product launches and Product Expansions:
8.2 Medtronic PLC
8.2.1 Company overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.3 Terumo Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.4 Fresenius SE & Co. KGaA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent Strategies and Developments
8.4.5.1 Acquisitions and Mergers:
8.5 Cardinal Health, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.6 Pfizer, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional & Segmental Analysis
8.6.4 Research & Development Expense
8.7 Teleflex, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Baxter International, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent Strategies and Developments
8.8.5.1 Approvals and Trials:
8.8.5.2 Acquisitions and Mergers:
8.9 Smiths Group PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent Strategies and Developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.10. AngioDynamics, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
Unique Offerings 